Atlas Trials

Safety of Sublingual dmLT for ETEC

Clinical trial NCT02052934 · COMPLETED

Trial details

NCT number
NCT02052934
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastroenteritis Escherichia Coli
Start date
2014-03-10
Primary completion
2016-11-02
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.